Call for ASAS Fellowships
The call for ASAS Fellowships is closed.
Purpose of the ASAS Fellowship
- To stimulate interest in clinical research in young investigators with an interest in spondyloarthritis in initiating or further developing their clinical research skills.
- To establish a mentoring relationship between a fellow and a mentor working at an ASAS centre to perform clinical research in axial and peripheral SpA (preferably outside of the applicant’s country) for 6-12 months.
Conditions and requirements
- Applicants ≤40 years of age, at an early stage of the research career and who are not an ASAS member.
- Applicants go to an ASAS centre other than their own centre, located at least in another city than the applicant’s institution, preferably also in another country. An ASAS centre is defined as a centre with ≥1 ASAS full member.
- The research project should focus on clinical research (i.e. not basic research) in SpA (including axSpA and pSpA, but not on PsA).
- Fluent in English or in the language of the hosting country.
- Stipend: up to 2 fellowships per year, € 25.000 each, intended to support travel, accommodation and living costs only. Duration: 6-12 months.
- The research project should start after granting the fellowship.
- Approved projects should be completed by the end of the award period.
- The results of the scientific work will be presented during the annual ASAS workshop. Abstract submissions to the annual EULAR and ACR meetings and the SpA Congress in Gent are encouraged. Full publications of the projects are expected.
- Funding of ASAS should be acknowledged in all communications.
Guidelines for the ASAS Fellowship
Application should include:
- ASAS fellowship application form
- Letter of support from two mentors (not the fellowship host, can be non-ASAS members)
- Applicant CV
- Host mentor CV
- Application form filled by applicant and host center should be submitted to firstname.lastname@example.org
- Award selection will be performed by the Executive and Advisory Committees. Committee members supporting grant applications (or working in the same centre) will be recused from the
selection process of the individual application in conflict.
Awarded ASAS Fellowships
2022 ASAS Fellowships
- no fellowships awarded
2021 ASAS Fellowships
- Paras Karmacharya, Project “Accumulation of Comorbidities and Association with Disease Activity and Functional Impairment in Ankylosing Spondylitis: data from the PSOAS cohort”, Nashville, USA
2020 ASAS Fellowships
- Murat Torgutalp, Project “Long-term evolution of radiographic sacroilitis progression in patients with axial spondyloarthritis: a 10-year prospective follow-up of the German spondyloarthritis cohort (GESPIC)”, Berlin, Germany
- Torgutalp M, Rios-Rodriguez V, Proft F, et al. Treatment with tumor necrosis factor inhibitors is associated with a time-shifted retardation of radiographic sacroiliitis progression in patients with axial spondyloarthritis: 10-year results from the German Spondyloarthritis Inception Cohort. Arthritis Rheumatol 2022 Sep;74(9):1515-1523
- Xabier Michelena Vegas, Project “Prevalence of extra-articular manifestations in axial spondyloarthritis (and psoriatic arthritis): Exploring its association with disease duration and gender”, Leeds, UK
- Michelena X, Zhao SS, Marco-Pascual S, et al. Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA. Rheumatology (Oxford). 2023 May 15;kead225
- Jacqueline So, Project: “The association of gut inflammation and axial inflammation in sponyloarthriits patients in Hong Kong”, Gent, Belgium
2019 ASAS Fellowships
- Augusta Ortolan, Project “Calculating the Ankylosing Spondylitis Disease Activity Score (ASDAS) in radiographic and non-radiographic axial spondyloarthritis when patient global assessement (PGA) is not available”, Leiden, The Netherlands
- Ortolan A, Ramiro S, van Gaalen F, et al. Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable. Rheumatology (Oxford). 2021 Feb 1;60(2):638-648
- Jean Liew, Project “Association of NSAID use and incident hypertension in ankylosing spondylitis”, San Francisco, US
- Liew JW, Ward MM, Reveille JD, et al. Nonsteroidal antiinflammatory drug use and association with incident hypertension in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2020 Nov;72(11):1645-1652
- Gilian Fitzgerald, Project “Beyond the Spine: Longitudinal analysis of extra-articular events in axial spondyloarthritis”, Toronto, Canada
2018 ASAS Fellowships
- Mikhail Protopopov, Project: “Development of the ASAS Case Library”, Berlin, Germany
2017 ASAS Fellowships
- Anthony So – Toronto, Canada
2016 ASAS Fellowships
- Bhowmik Meghnathi – Paris, France
- Sebastián Ibáñez, Project: “Body composition in spondyloarthritis”, Amsterdam, The Netherlands
- Ibáñez-Vodnizza, Cisman IM, van Denderen C, et al. Muscle wasting in male TNF-alpha blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition. Rheumatology (Oxford). 2017 Sep 1;56(9):1566-1572
2015 ASAS Fellowships
- Jonathan Chan, Project: “Prevalence of sacroiliitis on CT scan in inflammatory bowel disease”, Toronto, Canada
- Chan J, Sari I, Salonen D, et al. Development of a screening tool for the identification of sacroiliitis in Computed Tomography scans of the abdomen. J Rheumatol. 2016 Sep;43(9):1687-94
- Chan J, Sari I, Salonen D, et al. Prevalence of sacroiliitis in inflammatory bowel disease using a standardized Computed Tomography scoring system. Arthritis Care Res (Hoboken). 2018;May;70(5):807-810
- Alexandre Sepriano, Project: “Retention rate and predictive factors of TNF blockers”, Leiden, The Netherlands
- Sepriano A, Ramiro S, van der Heijde D, et al. Effect of comedication with conventional synthetic disease-modifying anti rheumatic drugs on retention or tumor necrosis factor inhibitors in patients with spondyloarthritis: a prospective cohort study. Arthritis Rheumatol. 2016 Nov;68(11):2671-2679
2014 ASAS Fellowships
- Aleksandra Fedorova – Berlin, Germany
2013 ASAS Fellowships
- Dinny Wallis, Project: “Infection risk in Ankylosing Spondylitis: an observational study”, Toronto, Canada
- Wallis D, Thavaneswaran A, Haroon N, et al. Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort. Rheumatology (Oxford). 2015 Jan;54(1):152-6
2012 ASAS Fellowships
- Wilson Bautista, Project: “Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis”, Leiden, The Netherlands
- Inna Gaydukova – Berlin, Germany
- José Castillo-Ortiz, Project: “Which contextual factors are important when analysing and interpreting work related outcomes in Ankylosing Spondylitis and how can we assess them”, Maastricht, The Netherlands
- Castillo-Ortiz JD, Ramiro S, Landewé R, et al. Work outcome in patients with ankylosing spondylitis: results from a 12-year follow up of an international study. Arthritis Care Res (Hoboken). 2016 Apr;68(4):544-52